<DOC>
	<DOCNO>NCT02259972</DOCNO>
	<brief_summary>To investigate safety , tolerability , pharmacokinetics incl . dose proportionality BI 113823 , well relative bioavailability PiB vs. tablet tablet fast vs. fed ( food effect tablet ) .</brief_summary>
	<brief_title>Safety , Tolerability Pharmacokinetics Single Rising Oral Doses BI 113823 Powder Bottle ( PiB ) Tablet Healthy Male Volunteers</brief_title>
	<detailed_description />
	<criteria>1 . Healthy male accord follow criterion : Based upon complete medical history , include physical examination , vital sign ( BP , PR ) , 12lead ECG , clinical laboratory test 2 . Age ≥18 Age ≤45 year 3 . BMI ≥18.5 BMI ≤29.9 kg/m2 ( Body Mass Index ) 4 . Signed date write informed consent prior admission study accordance GCP local legislation 1 . Any finding medical examination ( include BP , PR ECG ) deviate normal clinical relevance 2 . Any evidence clinically relevant concomitant disease 3 . Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder 4 . Surgery gastrointestinal tract ( except appendectomy ) 5 . Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder 6 . History relevant orthostatic hypotension , faint spell blackouts 7 . Chronic relevant acute infection 8 . History relevant allergy/hypersensitivity ( include allergy drug excipients ) 9 . Intake drug long halflife ( &gt; 24 hour ) within least one month le 10 halflives respective drug prior administration 10 . Use drug might reasonably influence result trial prolong QT/QTc interval base knowledge time protocol preparation within 10 day prior administration 11 . Participation another trial investigational drug within two month prior administration trial 12 . Smoker ( &gt; 10 cigarette &gt; 3 cigar &gt; 3 pipes/day ) 13 . Inability refrain smoke trial day 14 . Alcohol abuse ( 30 g/day ) 15 . Drug abuse 16 . Blood donation ( 100 mL within four week prior administration ) 17 . Excessive physical activity ( within one week prior administration ) 18 . Any laboratory value outside reference range clinical relevance 19 . Inability comply dietary regimen trial site 20 . Bradycardia &lt; 50/min , PR interval &gt; 200 m , QRS interval &gt; 110 m , QTcB &gt; 450 m , QT ( uncorrected ) &gt; 470 m relevant ECG finding screen 21 . A history additional risk factor Torsades de Pointes ( e.g. , heart failure , hypokalemia , family history Long QT Syndrome )</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>